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[57] ABSTRACT 
Optically active nornicotine compounds as a treatment for 
dopamine-related conditions and disease states. Such dis 
ease states include the treatment of myasthenia gravis. 
Parkinson’s disease. Alzheimer’s disease. schizophrenia. 
eating disorders. ulcers. drug addiction and as a substitute 
for psycho-stimulant self-administration. 
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